Jpmorgan Chase & CO X Biotech Inc. Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in X Biotech Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 8,694 shares of XBIT stock, worth $33,732. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,694
Previous 7,924
9.72%
Holding current value
$33,732
Previous $40,000
67.5%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding XBIT
# of Institutions
50Shares Held
4.87MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY1.13MShares$4.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.06MShares$4.12 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA452KShares$1.75 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny281KShares$1.09 Million0.0% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL254KShares$984,6270.0% of portfolio
About XBiotech Inc.
- Ticker XBIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,439,300
- Market Cap $118M
- Description
- XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...